Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Becton DickinsonXSWX:BDX -0.63%79 Equity-to-Asset is 0.48 as of Jun. 2026, which is 7% above its 10-year median of 0.45. GuruFocus rates XSWX:BDX with a GF Score™ of 79/100 and a GF Value™ of CHF157.49. The stock has 7 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Becton Dickinson ranks worse than 69.56% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Becton Dickinson's Total Stockholders Equity for the quarter that ended in Jun. 2026 was CHF19,516 Mil. Becton Dickinson's Total Assets for the quarter that ended in Jun. 2026 was CHF40,549 Mil.
Therefore, Becton Dickinson's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.48.
The historical rank and industry rank for Becton Dickinson's Equity-to-Asset or its related term are showing as below:
XSWX:BDX'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3 Med: 0.45 Max: 0.49
Current: 0.48
During the past 13 years, the highest Equity to Asset Ratio of Becton Dickinson was 0.49. The lowest was 0.30. And the median was 0.45.
XSWX:BDX's Equity-to-Asset is ranked worse than 69.56% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XSWX:BDX: 0.48
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Becton Dickinson Equity-to-Asset Related Terms
Becton Dickinson Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BDX vs MDLN, RMD, WST: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Becton Dickinson's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Becton Dickinson's Equity to Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (XSWX:BDX) has a Equity-to-Asset of 0.48 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Becton Dickinson and its competitors. This is near median its historical median of 0.45. Over the past decade, Becton Dickinson's Equity-to-Asset has ranged from 0.30 to 0.49. According to the industry distribution chart, Becton Dickinson ranks #594 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 69.6%.
Is Becton Dickinson's Equity-to-Asset too high?
Becton Dickinson's current Equity-to-Asset of 0.48 is near median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 0.49. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Becton Dickinson's value of 0.48 is 25% below this industry median. Based on the distribution chart, Becton Dickinson ranks #594 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Becton Dickinson has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Equity-to-Asset compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #594 out of 854 companies for Equity-to-Asset. This places Becton Dickinson in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Becton Dickinson's value of 0.48 is 25% below this benchmark. Historically, Becton Dickinson's own Equity-to-Asset has ranged from 0.30 to 0.49 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 0.64, Becton Dickinson has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current Equity-to-Asset of 0.48 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current Equity-to-Asset is 0.48, which is near median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current Equity-to-Asset of 0.48. The stock's GF Value™ is CHF157.49, compared to a current price of CHF142.54 — trading 9.5% below its estimated fair value. The current Equity-to-Asset is 0.48, which is near median its 10-year median of 0.45 and 25% below the Medical Devices & Instruments industry median of 0.64. Becton Dickinson's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current Equity-to-Asset is 0.48 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of CHF142.54 is trading 9.5% below its estimated GF Value™ of CHF157.49.
Key valuation signals for XSWX:BDX:
Equity-to-Asset: 0.48 (near median its 10-year median of 0.45)
GF Value™: CHF157.49 vs. price of CHF142.54 (9.5% below fair value)
Industry Position: 25% below the Medical Devices & Instruments median (#594 of 854)
No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
79GF Score
Get the complete analysis for XSWX:BDX
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BDX has been successfully added to your 
